Global Glucagon Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher Name :
Date: 10-Nov-2017
No. of pages: 117

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Scope of the Report:

This report focuses on the Glucagon in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Novo Nordisk

- Eli Lilly

- Fresenius Kabi

- Torrent Labs

- Taj Pharmaceuticals

- Xeris Pharmaceuticals

Market Segment by Regions, regional analysis covers

- North America (USA, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Columbia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Inject Glucagon

- Nasal Glucagon

Market Segment by Applications, can be divided into

- Emergency Kits

- General Use

- Diagnostic & Motility

- Cardiogenic Shock

- Others

There are 15 Chapters to deeply display the global Glucagon market.

Chapter 1, to describe Glucagon Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Glucagon, with sales, revenue, and price of Glucagon, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Glucagon, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Glucagon market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Glucagon sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Glucagon Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Glucagon Introduction
1.2 Market Analysis by Type
1.2.1 Inject Glucagon
1.2.2 Nasal Glucagon
1.3 Market Analysis by Applications
1.3.1 Emergency Kits
1.3.2 General Use
1.3.3 Diagnostic & Motility
1.3.4 Cardiogenic Shock
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Glucagon Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Glucagon Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Fresenius Kabi
2.3.1 Business Overview
2.3.2 Glucagon Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Torrent Labs
2.4.1 Business Overview
2.4.2 Glucagon Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Taj Pharmaceuticals
2.5.1 Business Overview
2.5.2 Glucagon Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Xeris Pharmaceuticals
2.6.1 Business Overview
2.6.2 Glucagon Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Glucagon Market Competition, by Manufacturer
3.1 Global Glucagon Sales and Market Share by Manufacturer
3.2 Global Glucagon Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon Manufacturer Market Share
3.3.2 Top 6 Glucagon Manufacturer Market Share
3.4 Market Competition Trend
4 Global Glucagon Market Analysis by Regions
4.1 Global Glucagon Sales, Revenue and Market Share by Regions
4.1.1 Global Glucagon Sales by Regions (2012-2017)
4.1.2 Global Glucagon Revenue by Regions (2012-2017)
4.2 North America Glucagon Sales and Growth (2012-2017)
4.3 Europe Glucagon Sales and Growth (2012-2017)
4.4 Asia-Pacific Glucagon Sales and Growth (2012-2017)
4.5 South America Glucagon Sales and Growth (2012-2017)
4.6 Middle East and Africa Glucagon Sales and Growth (2012-2017)
5 North America Glucagon by Countries
5.1 North America Glucagon Sales, Revenue and Market Share by Countries
5.1.1 North America Glucagon Sales by Countries (2012-2017)
5.1.2 North America Glucagon Revenue by Countries (2012-2017)
5.2 USA Glucagon Sales and Growth (2012-2017)
5.3 Canada Glucagon Sales and Growth (2012-2017)
5.4 Mexico Glucagon Sales and Growth (2012-2017)
6 Europe Glucagon by Countries
6.1 Europe Glucagon Sales, Revenue and Market Share by Countries
6.1.1 Europe Glucagon Sales by Countries (2012-2017)
6.1.2 Europe Glucagon Revenue by Countries (2012-2017)
6.2 Germany Glucagon Sales and Growth (2012-2017)
6.3 UK Glucagon Sales and Growth (2012-2017)
6.4 France Glucagon Sales and Growth (2012-2017)
6.5 Russia Glucagon Sales and Growth (2012-2017)
6.6 Italy Glucagon Sales and Growth (2012-2017)
7 Asia-Pacific Glucagon by Countries
7.1 Asia-Pacific Glucagon Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Glucagon Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Glucagon Revenue by Countries (2012-2017)
7.2 China Glucagon Sales and Growth (2012-2017)
7.3 Japan Glucagon Sales and Growth (2012-2017)
7.4 Korea Glucagon Sales and Growth (2012-2017)
7.5 India Glucagon Sales and Growth (2012-2017)
7.6 Southeast Asia Glucagon Sales and Growth (2012-2017)
8 South America Glucagon by Countries
8.1 South America Glucagon Sales, Revenue and Market Share by Countries
8.1.1 South America Glucagon Sales by Countries (2012-2017)
8.1.2 South America Glucagon Revenue by Countries (2012-2017)
8.2 Brazil Glucagon Sales and Growth (2012-2017)
8.3 Argentina Glucagon Sales and Growth (2012-2017)
8.4 Columbia Glucagon Sales and Growth (2012-2017)
9 Middle East and Africa Glucagon by Countries
9.1 Middle East and Africa Glucagon Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Glucagon Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Glucagon Revenue by Countries (2012-2017)
9.2 Saudi Arabia Glucagon Sales and Growth (2012-2017)
9.3 UAE Glucagon Sales and Growth (2012-2017)
9.4 Egypt Glucagon Sales and Growth (2012-2017)
9.5 Nigeria Glucagon Sales and Growth (2012-2017)
9.6 South Africa Glucagon Sales and Growth (2012-2017)
10 Global Glucagon Market Segment by Type
10.1 Global Glucagon Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Glucagon Sales and Market Share by Type (2012-2017)
10.1.2 Global Glucagon Revenue and Market Share by Type (2012-2017)
10.2 Inject Glucagon Sales Growth and Price
10.2.1 Global Inject Glucagon Sales Growth (2012-2017)
10.2.2 Global Inject Glucagon Price (2012-2017)
10.3 Nasal Glucagon Sales Growth and Price
10.3.1 Global Nasal Glucagon Sales Growth (2012-2017)
10.3.2 Global Nasal Glucagon Price (2012-2017)
11 Global Glucagon Market Segment by Application
11.1 Global Glucagon Sales Market Share by Application (2012-2017)
11.2 Emergency Kits Sales Growth (2012-2017)
11.3 General Use Sales Growth (2012-2017)
11.4 Diagnostic & Motility Sales Growth (2012-2017)
11.5 Cardiogenic Shock Sales Growth (2012-2017)
11.6 Others Sales Growth (2012-2017)
12 Glucagon Market Forecast (2017-2022)
12.1 Global Glucagon Sales, Revenue and Growth Rate (2017-2022)
12.2 Glucagon Market Forecast by Regions (2017-2022)
12.2.1 North America Glucagon Market Forecast (2017-2022)
12.2.2 Europe Glucagon Market Forecast (2017-2022)
12.2.3 Asia-Pacific Glucagon Market Forecast (2017-2022)
12.2.4 South America Glucagon Market Forecast (2017-2022)
12.2.5 Middle East and Africa Glucagon Market Forecast (2017-2022)
12.3 Glucagon Market Forecast by Type (2017-2022)
12.4 Glucagon Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Glucagon Picture
Table Product Specifications of Glucagon
Figure Global Sales Market Share of Glucagon by Types in 2016
Table Glucagon Types for Major Manufacturers
Figure Inject Glucagon Picture
Figure Nasal Glucagon Picture
Table Glucagon Sales Market Share by Applications in 2016
Figure Emergency Kits Picture
Figure General Use Picture
Figure Diagnostic & Motility Picture
Figure Cardiogenic Shock Picture
Figure Others Picture
Figure USA Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure France Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure UK Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure China Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure India Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Glucagon Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Glucagon Revenue (Value) and Growth Rate (2012-2022)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Glucagon Type and Applications
Table Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Glucagon Type and Applications
Table Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius Kabi Glucagon Type and Applications
Table Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Torrent Labs Basic Information, Manufacturing Base and Competitors
Table Torrent Labs Glucagon Type and Applications
Table Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Glucagon Type and Applications
Table Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Xeris Pharmaceuticals Glucagon Type and Applications
Table Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Glucagon Sales by Manufacturer (2016-2017)
Figure Global Glucagon Sales Market Share by Manufacturer in 2016
Figure Global Glucagon Sales Market Share by Manufacturer in 2017
Table Global Glucagon Revenue by Manufacturer (2016-2017)
Figure Global Glucagon Revenue Market Share by Manufacturer in 2016
Figure Global Glucagon Revenue Market Share by Manufacturer in 2017
Figure Global Glucagon Sales and Growth (2012-2017)
Figure Global Glucagon Revenue and Growth (2012-2017)
Table Global Glucagon Sales by Regions (2012-2017)
Table Global Glucagon Sales Market Share by Regions (2012-2017)
Table Global Glucagon Revenue by Regions (2012-2017)
Table Global Glucagon Revenue Market Share by Regions in 2012
Table Global Glucagon Revenue Market Share by Regions in 2016
Figure North America Glucagon Sales and Growth (2012-2017)
Figure Europe Glucagon Sales and Growth (2012-2017)
Figure Asia-Pacific Glucagon Sales and Growth (2012-2017)
Figure South America Glucagon Sales and Growth (2012-2017)
Figure Middle East and Africa Glucagon Sales and Growth (2012-2017)
Figure North America Glucagon Revenue and Growth (2012-2017)
Table North America Glucagon Sales by Countries (2012-2017)
Table North America Glucagon Sales Market Share by Countries (2012-2017)
Figure North America Glucagon Sales Market Share by Countries in 2012
Figure North America Glucagon Sales Market Share by Countries in 2016
Table North America Glucagon Revenue by Countries (2012-2017)
Table North America Glucagon Revenue Market Share by Countries (2012-2017)
Figure North America Glucagon Revenue Market Share by Countries in 2012
Figure North America Glucagon Revenue Market Share by Countries in 2016
Figure USA Glucagon Sales and Growth (2012-2017)
Figure Canada Glucagon Sales and Growth (2012-2017)
Figure Mexico Glucagon Sales and Growth (2012-2017)
Figure Europe Glucagon Revenue and Growth (2012-2017)
Table Europe Glucagon Sales by Countries (2012-2017)
Table Europe Glucagon Sales Market Share by Countries (2012-2017)
Table Europe Glucagon Revenue by Countries (2012-2017)
Table Europe Glucagon Revenue Market Share by Countries in 2012
Table Europe Glucagon Revenue Market Share by Countries in 2016
Figure Germany Glucagon Sales and Growth (2012-2017)
Figure UK Glucagon Sales and Growth (2012-2017)
Figure France Glucagon Sales and Growth (2012-2017)
Figure Russia Glucagon Sales and Growth (2012-2017)
Figure Italy Glucagon Sales and Growth (2012-2017)
Figure Asia-Pacific Glucagon Revenue and Growth (2012-2017)
Table Asia-Pacific Glucagon Sales by Countries (2012-2017)
Table Asia-Pacific Glucagon Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Glucagon Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Glucagon Revenue by Countries (2012-2017)
Table Asia-Pacific Glucagon Revenue Market Share by Countries (2012-2017)
Figure China Glucagon Sales and Growth (2012-2017)
Figure Japan Glucagon Sales and Growth (2012-2017)
Figure Korea Glucagon Sales and Growth (2012-2017)
Figure India Glucagon Sales and Growth (2012-2017)
Figure Southeast Asia Glucagon Sales and Growth (2012-2017)
Figure South America Glucagon Revenue and Growth (2012-2017)
Table South America Glucagon Sales by Countries (2012-2017)
Table South America Glucagon Sales Market Share by Countries (2012-2017)
Figure South America Glucagon Sales Market Share by Countries in 2016
Table South America Glucagon Revenue by Countries (2012-2017)
Table South America Glucagon Revenue Market Share by Countries (2012-2017)
Figure South America Glucagon Revenue Market Share by Countries in 2012
Figure South America Glucagon Revenue Market Share by Countries in 2016
Figure Brazil Glucagon Sales and Growth (2012-2017)
Figure Argentina Glucagon Sales and Growth (2012-2017)
Figure Columbia Glucagon Sales and Growth (2012-2017)
Figure Middle East and Africa Glucagon Revenue and Growth (2012-2017)
Table Middle East and Africa Glucagon Sales by Countries (2012-2017)
Table Middle East and Africa Glucagon Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Glucagon Sales Market Share by Countries in 2016
Table Middle East and Africa Glucagon Revenue by Countries (2012-2017)
Table Middle East and Africa Glucagon Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Glucagon Revenue Market Share by Countries in 2012
Figure Middle East and Africa Glucagon Revenue Market Share by Countries in 2016
Figure Saudi Arabia Glucagon Sales and Growth (2012-2017)
Figure UAE Glucagon Sales and Growth (2012-2017)
Figure Egypt Glucagon Sales and Growth (2012-2017)
Figure Nigeria Glucagon Sales and Growth (2012-2017)
Figure South Africa Glucagon Sales and Growth (2012-2017)
Table Global Glucagon Sales by Type (2012-2017)
Table Global Glucagon Sales Share by Type (2012-2017)
Table Global Glucagon Revenue by Type (2012-2017)
Table Global Glucagon Revenue Share by Type (2012-2017)
Figure Global Inject Glucagon Sales Growth (2012-2017)
Figure Global Inject Glucagon Price (2012-2017)
Figure Global Nasal Glucagon Sales Growth (2012-2017)
Figure Global Nasal Glucagon Price (2012-2017)
Table Global Glucagon Sales by Application (2012-2017)
Table Global Glucagon Sales Share by Application (2012-2017)
Figure Global Emergency Kits Sales Growth (2012-2017)
Figure Global General Use Sales Growth (2012-2017)
Figure Global Diagnostic & Motility Sales Growth (2012-2017)
Figure Global Cardiogenic Shock Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Glucagon Sales, Revenue and Growth Rate (2017 -2022)
Table Global Glucagon Sales Forecast by Regions (2017-2022)
Table Global Glucagon Market Share Forecast by Regions (2017-2022)
Figure North America Sales Glucagon Market Forecast (2017-2022)
Figure Europe Sales Glucagon Market Forecast (2017-2022)
Figure Asia-Pacific Sales Glucagon Market Forecast (2017-2022)
Figure South America Sales Glucagon Market Forecast (2017-2022)
Figure Middle East and Africa Sales Glucagon Market Forecast (2017-2022)
Table Global Glucagon Sales Forecast by Type (2017-2022)
Table Global Glucagon Market Share Forecast by Type (2017-2022)
Table Global Glucagon Sales Forecast by Application (2017-2022)
Table Global Glucagon Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
  • United States Diabetes Drugs Market Report 2017
    Published: 15-Nov-2017        Price: US 3800 Onwards        Pages: 124
    In this report, the United States Diabetes Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of D......
  • Global Insulin Market Research Report 2017
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Insulin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Sout......
  • United States Glucagon Market Report 2017
    Published: 13-Nov-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Glucagon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Glucago......
  • United States Lixisenatide Market Report 2017
    Published: 13-Nov-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Lixisenatide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Lix......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists in these regions, from 2012 to 2022 (forecast), covering - North A......
  • Global Diabetes Drugs Sales Market Report 2017
    Published: 10-Nov-2017        Price: US 4000 Onwards        Pages: 128
    In this report, the global Diabetes Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan ......
  • Global Liraglutide Market Professional Survey Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 100
    This report studies Liraglutide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - HEC Pharm - Teva - Bachem - Bharat Pharmaceuticals - Kingpep Biot......
  • United States Antidiabetic Biguanides Market Report 2017
    Published: 09-Nov-2017        Price: US 3800 Onwards        Pages: 113
    In this report, the United States Antidiabetic Biguanides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and......
  • United States Antidiabetic SGLT-2 Inhibitor Market Report 2017
    Published: 09-Nov-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Antidiabetic SGLT-2 Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs